These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25587908)

  • 1. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
    Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
    AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease.
    Wang Z; Molsberry SA; Cheng Y; Kingsley L; Levine AJ; Martin E; Munro CA; Ragin A; Rubin LH; Sacktor N; Seaberg EC; Becker JT;
    AIDS; 2019 Nov; 33(14):2115-2124. PubMed ID: 31335803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
    Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
    J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy.
    Schouten J; Su T; Wit FW; Kootstra NA; Caan MW; Geurtsen GJ; Schmand BA; Stolte IG; Prins M; Majoie CB; Portegies P; Reiss P;
    AIDS; 2016 Apr; 30(7):1027-38. PubMed ID: 26752277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients.
    Janssen MA; Bosch M; Koopmans PP; Kessels RP
    J Neurovirol; 2015 Aug; 21(4):383-90. PubMed ID: 25678141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
    Vassallo M; Durant J; Biscay V; Lebrun-Frenay C; Dunais B; Laffon M; Harvey-Langton A; Cottalorda J; Ticchioni M; Carsenti H; Pradier C; Dellamonica P
    AIDS; 2014 Feb; 28(4):493-501. PubMed ID: 24472743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
    Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
    Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment.
    Underwood J; De Francesco D; Leech R; Sabin CA; Winston A;
    PLoS One; 2018; 13(4):e0194760. PubMed ID: 29641619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Development in Perinatally Human Immunodeficiency Virus-infected Adolescents on Long-term Treatment, Compared to Healthy Matched Controls: A Longitudinal Study.
    Van den Hof M; Ter Haar AM; Scherpbier HJ; van der Lee JH; Reiss P; Wit FWNM; Oostrom KJ; Pajkrt D
    Clin Infect Dis; 2020 Mar; 70(7):1364-1371. PubMed ID: 31106812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological tests associated with symptomatic HIV-associated neurocognitive disorder (HAND) in a cohort of older adults in Tanzania.
    Fotheringham L; Lawson RA; Urasa S; Boshe J; Mukaetova-Ladinska EB; Rogathi J; Howlett W; Dekker MCJ; Gray WK; Evans J; Walker RW; Makupa PC; Paddick SM
    J Int Neuropsychol Soc; 2024 Aug; 30(7):660-670. PubMed ID: 38766814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 infection and cognitive impairment in the cART era: a review.
    Schouten J; Cinque P; Gisslen M; Reiss P; Portegies P
    AIDS; 2011 Mar; 25(5):561-75. PubMed ID: 21160410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.
    Muñoz-Moreno JA; Prats A; Pérez-Álvarez N; Fumaz CR; Garolera M; Doval E; Negredo E; Ferrer MJ; Clotet B;
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):585-92. PubMed ID: 24135776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.
    Janssen MA; Meulenbroek O; Steens SC; Góraj B; Bosch M; Koopmans PP; Kessels RP
    AIDS; 2015 Oct; 29(16):2139-48. PubMed ID: 26544578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.
    Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA
    Clin Infect Dis; 2016 Sep; 63(5):687-693. PubMed ID: 27325690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
    Sanford R; Fellows LK; Ances BM; Collins DL
    JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa.
    Lowick S; Sawry S; Meyers T
    Psychol Health Med; 2012; 17(5):599-610. PubMed ID: 22313239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.